PROTECT-L

Breaking Treatment Resistance in Childhood AML

Our team investigate why acute myeloid leukemia in children resists current therapy, and develop innovative strategies to make treatments more effective, less toxic, and more durable.
By combining molecular biology, genomics, functional screening, and translational research, our goal is to improve outcomes for every child diagnosed with AML.